Vertex Pharmaceuticals (VX1) Q3 2022 Earnings Report
23 Followers
DE:VX1 Q3 2022 EPS Results
- Actual EPS
- EUR 3.56
- Consensus EPS
- EUR 3.21
- Beat/Miss
- Beat by +EUR 0.35
- One Year Ago EPS
- EUR 3.16
DE:VX1 Q3 2022 Revenue Results
- Actual Revenue
- EUR 2.02B
- Expected Revenue
- EUR 1.98B
- Beat/Miss
- Beat by +EUR 34.73M
- YoY Revenue Growth
- +14.06%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 10/27/2022
- Time
- After Close
- Conference Call
- Thursday, October 27, 2022
DE:VX1 Upcoming Earnings
Vertex Pharmaceuticals's next earnings date is estimated for February 9, 2027, based on past reporting schedules.
Q3 2022 Earnings Call Audio
DE:VX1 Q3 2022 Earnings Call
0:00 / 0:00
Q3 2022 Earnings Slide Deck
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:VX1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 09, 2027 | 2026 (Q4) | 3.76- | 4.47 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | 4.284.23 | 4.26 | -0.83% (-0.04) | |
| Aug 03, 2026 | 2026 (Q2) | 4.214.20 | 4.02 | 4.65% (+0.19) | |
| May 04, 2026 | 2026 (Q1) | 3.773.97 | 3.61 | 10.10% (+0.36) | |
| Feb 12, 2026 | 2025 (Q4) | 4.544.47 | 3.54 | 26.38% (+0.93) | |
| Nov 03, 2025 | 2025 (Q3) | 4.064.26 | 3.89 | 9.59% (+0.37) | |
| Aug 06, 2025 | 2025 (Q2) | 3.814.02 | -11.4 | 135.23% (+15.42) | |
| May 05, 2025 | 2025 (Q1) | 3.843.61 | 4.23 | -14.71% (-0.62) | |
| Feb 10, 2025 | 2024 (Q4) | 3.573.54 | 3.73 | -5.24% (-0.20) | |
| Nov 04, 2024 | 2024 (Q3) | 3.623.89 | 3.63 | 7.35% (+0.27) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
